当前位置: 首页 > 详情页

Significant reduction of peripheral blood interlieukin-35 and CD4(+)EBI3(+) T cells, which are negatively correlated with an increase in the plasma IL-17 and cTnI level, in viral myocarditis patients

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China [2]Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
出处:
ISSN:

关键词: viral disease myocarditis interleukin-35 EBI3

摘要:
Introduction: Viral myocarditis (VMC) has become an increasingly common heart disease that endangers human health. In the present study, the plasma interleukin-35 (IL-35) level and the percentage of CD4(+)EBI3(+) T cells in VMC patients were detected to investigate the significance of changes in these parameters in the plasma of VMC patients and their association with the disease. Material and methods: ELISA was performed to detect the plasma IL-35 level and the percentage of peripheral blood CD4(+)EBI3(+) T cells in 40 VMC patients and in 20 healthy individuals. Moreover, the plasma IL-17 levels in the VMC patients and in the healthy individuals were detected using an ELISA, and the cardiac Troponin-I (cTnI) levels were detected using a chemiluminescent microparticle immunoassay to compare the differences in the groups. Results: Plasma IL-35 level and the percentage of CD4(+)EBI3(+) T cells in acute phase VMC patients was lower than that in the healthy control group and the convalescent phase VMC patients. Additionally, the plasma IL-35 level in the VMC patients exhibited a negative correlation with the levels of cTnI and IL-17. The percentage of CD4(+)EBI3(+) T cells also showed a negative correlation with the levels of cTnI and IL-17. Conclusions: The plasma IL-35 level and the percentage of CD4(+)EBI3(+) T cells in VMC patients was reduced and the amount of the decrease was associated with the severity of the disease. These results suggest that IL-35 and CD4(+)EBI3(+) T might play important roles in the progression of VMC and could be used as indictors of the disease.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 免疫学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 免疫学
JCR分区:
出版当年[2015]版:
Q4 IMMUNOLOGY
最新[2023]版:
Q4 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
通讯作者:
通讯机构: [*1]Department of Cardiology, The Second Affiliated Hospital of Soochow University, 1055 San-Xiang Road, Suzhou, Jiangsu 215004, P.R. China [*2]Department of Nephrology, The Second Affiliated Hospital of Soochow University, 1055 San-Xiang Road, Suzhou, Jiangsu 215004, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院